Saturday, December 13, 2025
Saturday, December 13, 2025
- Advertisement -

Qualcomm’s budget chipsets for 5G smartphones in 2021

Snapdragon 4-series 5G mobile platform is designed to exceed expectations for the mass-market segment

Must Read

- Advertisement -
- Advertisement -
  • Xiaomi will become one of the first OEMs to have a smartphone powered by 4-series chips.
  • Oppo and Motorola have committed to drive large-scale adoption of 5G devices.

Bengaluru:  Qualcomm is accelerating its 5G global commercialisation at scale by expanding its portfolio of 5G mobile platforms to the budget Snapdragon 4-series chipsets in early 2021.

The chipset giant’s Snapdragon 8-series powered a few of the flagship 5 smartphones in 2019. This year, it has Snapdragon 865 lineup, Snapdragon 765, 768G, 765G and 690.

“Qualcomm continues to pave the way for 5G commercialization at scale, and the expansion of 5G into our Snapdragon 4-series is expected to address regions that currently have approximately 3.5 billion smartphone users combined,” Cristiano Amon, president of Qualcomm Incorporated, said.

He said the Snapdragon 4-series 5G mobile platform is designed to exceed expectations for the mass-market segment by bringing an assortment of predominately high- and mid-tier features to a broader audience.

“It will deliver on the promise of making 5G accessible to all smartphone users,” he said.

Xiaomi will become one of the world’s first OEMs to introduce a 5G smartphone powered by the Snapdragon 4-series 5G mobile platform even though Oppo and Motorola have committed to designing 5G phones powered by the new Snapdragon 4-series chipset.


Discover more from TechChannel News

Subscribe to get the latest posts sent to your email.

- Advertisement -

Latest News

ADI Foundation touts 2025 as a year “from concept to execution”

ADI Foundation Unveils government‑grade ADI Chain Mainnet and stablecoin plans

US to allow Nvidia’s H200 chip exports to China with 25% fee

Trump framies the move as a balance between national security and maintaining US leadership in AI.

Regulatory-approved medical apps surge globally

Fuelled by consumer preference for mobile health solutions and advances in smart device capabilities
- Advertisement -
- Advertisement -

More Articles

- Advertisement -